title: Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study.
authors.forename: M
authors.initials: M
authors.lastname: Dreyfus
authors.forename: D
authors.initials: D
authors.lastname: Barrois
authors.forename: J-Y
authors.initials: JY
authors.lastname: Borg
authors.forename: S
authors.initials: S
authors.lastname: Claeyssens
authors.forename: M-F
authors.initials: MF
authors.lastname: Torchet
authors.forename: B
authors.initials: B
authors.lastname: Arnuti
authors.forename: B
authors.initials: B
authors.lastname: Pautard
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005176:Factor XIII; D005177:Factor XIII Deficiency / Q000151:congenital / Q000628:therapy*; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents; D005176:Factor XIII; D005341:Fibrinolysin